Selected research
Market Structure
Global Automatic Solid Phase Peptide Synthesis Equipment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Automatic Solid Phase Peptide Synthesis Equipment market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Automatic Solid Phase Peptide Synthesis Equipment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Automatic Solid Phase Peptide Synthesis Equipment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Automatic Solid Phase Peptide Synthesis Equipment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Automatic Solid Phase Peptide Synthesis Equipment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Automatic Solid Phase Peptide Synthesis Equipment include Büchi AG, AAPPTec, CEM Corporation, Gyros Protein Technologies, Biotage and CSBio, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Automatic Solid Phase Peptide Synthesis Equipment market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Automatic Solid Phase Peptide Synthesis Equipment and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Automatic Solid Phase Peptide Synthesis Equipment sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Automatic Solid Phase Peptide Synthesis Equipment market size, projected growth trends, production technologies, key applications, and end-use industries.
Automatic Solid Phase Peptide Synthesis Equipment Segment by Company
Büchi AG
AAPPTec
CEM Corporation
Gyros Protein Technologies
Biotage
CSBio
Automatic Solid Phase Peptide Synthesis Equipment Segment by Type
Fully-automatic
Semi-automatic
Automatic Solid Phase Peptide Synthesis Equipment Segment by Application
Science and Research
Commercial
Automatic Solid Phase Peptide Synthesis Equipment Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Automatic Solid Phase Peptide Synthesis Equipment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Automatic Solid Phase Peptide Synthesis Equipment and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Automatic Solid Phase Peptide Synthesis Equipment.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Automatic Solid Phase Peptide Synthesis Equipment market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Automatic Solid Phase Peptide Synthesis Equipment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Automatic Solid Phase Peptide Synthesis Equipment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Automatic Solid Phase Peptide Synthesis Equipment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Fully-automatic
- Semi-automatic
Applications
- Science and Research
- Commercial
Companies covered
- Büchi AG
- AAPPTec
- CEM Corporation
- Gyros Protein Technologies
- Biotage
- CSBio
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Automatic Solid Phase Peptide Synthesis Equipment Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Automatic Solid Phase Peptide Synthesis Equipment Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Automatic Solid Phase Peptide Synthesis Equipment Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Automatic Solid Phase Peptide Synthesis Equipment Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Automatic Solid Phase Peptide Synthesis Equipment Market Dynamics
- 2.1 Automatic Solid Phase Peptide Synthesis Equipment Industry Trends
- 2.2 Automatic Solid Phase Peptide Synthesis Equipment Industry Drivers
- 2.3 Automatic Solid Phase Peptide Synthesis Equipment Industry Opportunities and Challenges
- 2.4 Automatic Solid Phase Peptide Synthesis Equipment Industry Restraints
3 Automatic Solid Phase Peptide Synthesis Equipment Market by Manufacturers
- 3.1 Global Automatic Solid Phase Peptide Synthesis Equipment Revenue by Manufacturers (2021-2026)
- 3.2 Global Automatic Solid Phase Peptide Synthesis Equipment Sales by Manufacturers (2021-2026)
- 3.3 Global Automatic Solid Phase Peptide Synthesis Equipment Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Automatic Solid Phase Peptide Synthesis Equipment Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Automatic Solid Phase Peptide Synthesis Equipment Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Automatic Solid Phase Peptide Synthesis Equipment Manufacturers, Product Type & Application
- 3.7 Global Automatic Solid Phase Peptide Synthesis Equipment Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Automatic Solid Phase Peptide Synthesis Equipment Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Automatic Solid Phase Peptide Synthesis Equipment Players Market Share by Revenue in 2025
- 3.8.3 2025 Automatic Solid Phase Peptide Synthesis Equipment Tier 1, Tier 2, and Tier 3
4 Automatic Solid Phase Peptide Synthesis Equipment Market by Type
- 4.1 Automatic Solid Phase Peptide Synthesis Equipment Type Introduction
- 4.1.1 Fully-automatic
- 4.1.2 Semi-automatic
- 4.2 Global Automatic Solid Phase Peptide Synthesis Equipment Sales by Type
- 4.2.1 Global Automatic Solid Phase Peptide Synthesis Equipment Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Automatic Solid Phase Peptide Synthesis Equipment Sales by Type (2021-2032)
- 4.2.3 Global Automatic Solid Phase Peptide Synthesis Equipment Sales Market Share by Type (2021-2032)
- 4.3 Global Automatic Solid Phase Peptide Synthesis Equipment Revenue by Type
- 4.3.1 Global Automatic Solid Phase Peptide Synthesis Equipment Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Automatic Solid Phase Peptide Synthesis Equipment Revenue by Type (2021-2032)
- 4.3.3 Global Automatic Solid Phase Peptide Synthesis Equipment Revenue Market Share by Type (2021-2032)
5 Automatic Solid Phase Peptide Synthesis Equipment Market by Application
- 5.1 Automatic Solid Phase Peptide Synthesis Equipment Application Introduction
- 5.1.1 Science and Research
- 5.1.2 Commercial
- 5.2 Global Automatic Solid Phase Peptide Synthesis Equipment Sales by Application
- 5.2.1 Global Automatic Solid Phase Peptide Synthesis Equipment Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Automatic Solid Phase Peptide Synthesis Equipment Sales by Application (2021-2032)
- 5.2.3 Global Automatic Solid Phase Peptide Synthesis Equipment Sales Market Share by Application (2021-2032)
- 5.3 Global Automatic Solid Phase Peptide Synthesis Equipment Revenue by Application
- 5.3.1 Global Automatic Solid Phase Peptide Synthesis Equipment Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Automatic Solid Phase Peptide Synthesis Equipment Revenue by Application (2021-2032)
- 5.3.3 Global Automatic Solid Phase Peptide Synthesis Equipment Revenue Market Share by Application (2021-2032)
6 Global Automatic Solid Phase Peptide Synthesis Equipment Sales by Region
- 6.1 Global Automatic Solid Phase Peptide Synthesis Equipment Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Automatic Solid Phase Peptide Synthesis Equipment Sales by Region (2021-2032)
- 6.2.1 Global Automatic Solid Phase Peptide Synthesis Equipment Sales by Region (2021-2026)
- 6.2.2 Global Automatic Solid Phase Peptide Synthesis Equipment Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Automatic Solid Phase Peptide Synthesis Equipment Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Automatic Solid Phase Peptide Synthesis Equipment Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Automatic Solid Phase Peptide Synthesis Equipment Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Automatic Solid Phase Peptide Synthesis Equipment Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Automatic Solid Phase Peptide Synthesis Equipment Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Automatic Solid Phase Peptide Synthesis Equipment Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Automatic Solid Phase Peptide Synthesis Equipment Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Automatic Solid Phase Peptide Synthesis Equipment Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Automatic Solid Phase Peptide Synthesis Equipment Revenue by Region
- 7.1 Global Automatic Solid Phase Peptide Synthesis Equipment Revenue by Region
- 7.1.1 Global Automatic Solid Phase Peptide Synthesis Equipment Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Automatic Solid Phase Peptide Synthesis Equipment Revenue by Region (2021-2026)
- 7.1.3 Global Automatic Solid Phase Peptide Synthesis Equipment Revenue by Region (2027-2032)
- 7.1.4 Global Automatic Solid Phase Peptide Synthesis Equipment Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Automatic Solid Phase Peptide Synthesis Equipment Revenue (2021-2032)
- 7.2.2 North America Automatic Solid Phase Peptide Synthesis Equipment Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Automatic Solid Phase Peptide Synthesis Equipment Revenue (2021-2032)
- 7.3.2 Europe Automatic Solid Phase Peptide Synthesis Equipment Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Automatic Solid Phase Peptide Synthesis Equipment Revenue (2021-2032)
- 7.4.2 Asia-Pacific Automatic Solid Phase Peptide Synthesis Equipment Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Automatic Solid Phase Peptide Synthesis Equipment Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Automatic Solid Phase Peptide Synthesis Equipment Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Büchi AG
- 8.1.1 Büchi AG Company Information
- 8.1.2 Büchi AG Business Overview
- 8.1.3 Büchi AG Automatic Solid Phase Peptide Synthesis Equipment Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Büchi AG Automatic Solid Phase Peptide Synthesis Equipment Product Portfolio
- 8.1.5 Büchi AG Recent Developments
- 8.2 AAPPTec
- 8.2.1 AAPPTec Company Information
- 8.2.2 AAPPTec Business Overview
- 8.2.3 AAPPTec Automatic Solid Phase Peptide Synthesis Equipment Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 AAPPTec Automatic Solid Phase Peptide Synthesis Equipment Product Portfolio
- 8.2.5 AAPPTec Recent Developments
- 8.3 CEM Corporation
- 8.3.1 CEM Corporation Company Information
- 8.3.2 CEM Corporation Business Overview
- 8.3.3 CEM Corporation Automatic Solid Phase Peptide Synthesis Equipment Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 CEM Corporation Automatic Solid Phase Peptide Synthesis Equipment Product Portfolio
- 8.3.5 CEM Corporation Recent Developments
- 8.4 Gyros Protein Technologies
- 8.4.1 Gyros Protein Technologies Company Information
- 8.4.2 Gyros Protein Technologies Business Overview
- 8.4.3 Gyros Protein Technologies Automatic Solid Phase Peptide Synthesis Equipment Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Gyros Protein Technologies Automatic Solid Phase Peptide Synthesis Equipment Product Portfolio
- 8.4.5 Gyros Protein Technologies Recent Developments
- 8.5 Biotage
- 8.5.1 Biotage Company Information
- 8.5.2 Biotage Business Overview
- 8.5.3 Biotage Automatic Solid Phase Peptide Synthesis Equipment Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Biotage Automatic Solid Phase Peptide Synthesis Equipment Product Portfolio
- 8.5.5 Biotage Recent Developments
- 8.6 CSBio
- 8.6.1 CSBio Company Information
- 8.6.2 CSBio Business Overview
- 8.6.3 CSBio Automatic Solid Phase Peptide Synthesis Equipment Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 CSBio Automatic Solid Phase Peptide Synthesis Equipment Product Portfolio
- 8.6.5 CSBio Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Automatic Solid Phase Peptide Synthesis Equipment Value Chain Analysis
- 9.1.1 Automatic Solid Phase Peptide Synthesis Equipment Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Automatic Solid Phase Peptide Synthesis Equipment Production Mode & Process
- 9.2 Automatic Solid Phase Peptide Synthesis Equipment Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Automatic Solid Phase Peptide Synthesis Equipment Distributors
- 9.2.3 Automatic Solid Phase Peptide Synthesis Equipment Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst